A 22-year-old man has successfully received a kidney from his 47-year-old father at AIIMS Bhopal, despite a blood group mismatch, according to a press release issued on Thursday. The patient had been suffering from chronic glomerulonephritis (CGN), a condition that inflames and damages the kidneys over time.
Blood Group Incompatibility Overcome
The patient's blood group was A positive, while his father's was AB positive. Ordinarily, this incompatibility would trigger rejection because the son's immune system carries anti-B antibodies. To prepare for the transplant, doctors placed the patient on a two-week course of immunosuppressive therapy. This included globulin treatment and other interventions to lower antibody levels, thereby reducing the risk of rejection.
Surgery and Recovery
The surgery was performed seven days ago, after the preparatory regimen. Post-operation, the patient continues on immunosuppressants to support the function of the new kidney. He is expected to be discharged within this week.
Expert Insights on ABO-Incompatible Transplants
ABO-incompatible transplants are demanding and require careful planning and techniques to suppress the immune response. By lowering antibody activity before surgery, doctors can make transplants possible even when blood groups do not match, said AIIMS nephrologist Dr. Mahendra Atlani. For the young man and his father, the procedure was not only a medical intervention but also a family decision shaped by necessity.
Expanding Options for Patients
In settings where access to compatible donors is limited, such approaches expand options for patients who might otherwise wait years for a match. At AIIMS Bhopal, this case reflects how evolving medical science is being applied in practice. It shows how families, even from less privileged backgrounds, can benefit from advanced transplant techniques when guided by clinical expertise.
The successful transplant highlights the growing capability of Indian medical institutions to perform complex procedures that were once considered impossible. As medical science advances, more patients with incompatible donors may find hope through such innovative treatments.
